The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse - PubMed (original) (raw)
. 1996 Jun 28;85(7):1009-23.
doi: 10.1016/s0092-8674(00)81302-1.
J L de la Pompa, C Sirard, R Mo, M Woo, A Hakem, A Wakeham, J Potter, A Reitmair, F Billia, E Firpo, C C Hui, J Roberts, J Rossant, T W Mak
Affiliations
- PMID: 8674108
- DOI: 10.1016/s0092-8674(00)81302-1
Free article
The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse
R Hakem et al. Cell. 1996.
Free article
Abstract
Mutations of the BRCA1 gone in humans are associated with predisposition to breast and ovarian cancers. We show here that Brca1+/- mice are normal and fertile and lack tumors by age eleven months. Homozygous Brca1(5-6) mutant mice die before day 7.5 of embryogenesis. Mutant embryos are poorly developed, with no evidence of mesoderm formation. The extraembryonic region is abnormal, but aggregation with wild-type tetraploid embryos does not rescue the lethality. In vivo, mutant embryos do not exhibit increased apoptosis but show reduced cell proliferation accompanied by decreased expression of cyclin E and mdm-2, a regulator of p53 activity. The expression of cyclin-dependent kinase inhibitor p21 is dramatically increased in the mutant embryos. Buttressing these in vivo observations is the fact that mutant blastocyst growth is grossly impaired in vitro. Thus, the death of Brca1(5-6) mutant embryos prior to gastrulation may be due to a failure of the proliferative burst required for the development of the different germ layers.
Similar articles
- Brca2 is required for embryonic cellular proliferation in the mouse.
Suzuki A, de la Pompa JL, Hakem R, Elia A, Yoshida R, Mo R, Nishina H, Chuang T, Wakeham A, Itie A, Koo W, Billia P, Ho A, Fukumoto M, Hui CC, Mak TW. Suzuki A, et al. Genes Dev. 1997 May 15;11(10):1242-52. doi: 10.1101/gad.11.10.1242. Genes Dev. 1997. PMID: 9171369 - Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation.
Hakem R, de la Pompa JL, Elia A, Potter J, Mak TW. Hakem R, et al. Nat Genet. 1997 Jul;16(3):298-302. doi: 10.1038/ng0797-298. Nat Genet. 1997. PMID: 9207798 - p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101.
Ruland J, Sirard C, Elia A, MacPherson D, Wakeham A, Li L, de la Pompa JL, Cohen SN, Mak TW. Ruland J, et al. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1859-64. doi: 10.1073/pnas.98.4.1859. Proc Natl Acad Sci U S A. 2001. PMID: 11172041 Free PMC article. - Tumor formation in Brca1 conditional mutant mice.
Deng CX. Deng CX. Environ Mol Mutagen. 2002;39(2-3):171-7. doi: 10.1002/em.10069. Environ Mol Mutagen. 2002. PMID: 11921186 Review. - [Progress in molecular genetics of correlating genes of breast cancer].
Wu Y, Yang L, Wei Y. Wu Y, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Apr;19(2):152-5. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002. PMID: 11941595 Review. Chinese.
Cited by
- Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing.
Pal T, Mundt E, Richardson ME, Chao E, Pesaran T, Slavin TP, Couch FJ, Monteiro ANA. Pal T, et al. NPJ Precis Oncol. 2024 Nov 2;8(1):247. doi: 10.1038/s41698-024-00741-4. NPJ Precis Oncol. 2024. PMID: 39488595 Free PMC article. - Shieldin and CST co-orchestrate DNA polymerase-dependent tailed-end joining reactions independently of 53BP1-governed repair pathway choice.
King A, Reichl PI, Metson JS, Parker R, Munro D, Oliveira C, Sommerova L, Becker JR, Biggs D, Preece C, Davies B, Chapman JR. King A, et al. Nat Struct Mol Biol. 2024 Sep 3. doi: 10.1038/s41594-024-01381-9. Online ahead of print. Nat Struct Mol Biol. 2024. PMID: 39227718 - Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors.
Zhu Y, Pei X, Novaj A, Setton J, Bronder D, Derakhshan F, Selenica P, McDermott N, Orman M, Plum S, Subramanyan S, Braverman SH, McMillan B, Sinha S, Ma J, Gazzo A, Khan A, Bakhoum S, Powell SN, Reis-Filho JS, Riaz N. Zhu Y, et al. Genome Med. 2024 Aug 28;16(1):108. doi: 10.1186/s13073-024-01371-y. Genome Med. 2024. PMID: 39198848 Free PMC article. - Male with an apparently normal phenotype carrying a BRCA1 exon 20 duplication in trans to a BRCA1 frameshift variant.
Block I, Mateu-Regué À, Do TTN, Miceikaite I, Sdogati D, Larsen MJ, Hao Q, Nielsen HR, Boonen SE, Skytte AB, Jensen UB, Høffding LK, De Nicolo A, Viel A, Tudini E, Parsons MT, Hansen TVO, Rossing M, Kruse TA, Spurdle AB, Thomassen M. Block I, et al. Breast Cancer Res. 2024 Jan 9;26(1):6. doi: 10.1186/s13058-023-01755-9. Breast Cancer Res. 2024. PMID: 38195559 Free PMC article. - Shieldin and CST co-orchestrate DNA polymerase-dependent tailed-end joining reactions independently of 53BP1-governed repair pathway choice.
King A, Reichl P, Metson JS, Parker R, Munro D, Oliveira C, Becker JR, Biggs D, Preece C, Davies B, Chapman JR. King A, et al. bioRxiv [Preprint]. 2023 Dec 21:2023.12.20.572534. doi: 10.1101/2023.12.20.572534. bioRxiv. 2023. PMID: 38187711 Free PMC article. Updated. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous